Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for recovery agitation in elective upper limb orthopedic surgery
IRCT20230819059181N1Phase 3Completed
- Sponsor
- Ardabil University of Medical Sciences
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of dexmedetomidine in agitation (2 arms), sponsored by Ardabil University of Medical Sciences. Primary endpoints: agitation and pain. Started Dec 2023; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
agitation
Beyond the preview
Go deeper on IRCT20230819059181N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230819059181N1.